Welcome to our dedicated page for Covalon Technologies news (Ticker: CVALF), a resource for investors and traders seeking the latest updates and insights on Covalon Technologies stock.
Covalon Technologies Ltd. reports company developments across advanced medical technologies for vascular access, infection prevention, wound care, and surgical consumables. Recurring updates describe clinical education, healthcare-conference activity, and product use around contamination of intravenous connections, healthcare-associated infection risk, skin integrity, and patient-care workflows.
Covalon news also includes fiscal results, management discussion and analysis availability, shareholder meeting matters, director compensation through deferred share units, and amendments to governance documents and incentive plans. Product-specific coverage includes solutions such as CovaClear IV Cover dressings and VALGuard Vascular Access Line Guard.
Covalon Technologies Ltd. (CVALF) is set to release its Fiscal 2020 Third Quarter financial results on August 24, 2020, prior to market opening. A conference call will be conducted at 9:00am EST on the same day to discuss these results. Investors can access the call via local and toll-free numbers provided. The results and related materials will be available on SEDAR and Covalon's investor relations site.